News Discover the latest news stories, blog posts and publications from Cobra's expert team. You are here: Home News Toggle filters Year: All Years 2019 2018 2017 2016 2015 2014 2013 2012 2011 or Month: All Months January February March April May June July August September October November December or Type: All Categories DNA Fill Finish General DNA Proteins Technologies Viral Vectors Alligator Bioscience AB Phase 1 Trial Benefits from Cobra Biologics' maxXpress Platform Alligator Bioscience AB Phase 1 Trial in Advanced Solid Tumours Benefits from Cobra Biologics' maxXpress Platform in Manufacturing Immuno-Oncology Antibody ADC-1013 Cobra Biologics and Tecrea Awarded £112K ($166K USD) Innovate UK Grant Cobra Biologics and Tecrea Awarded £112K ($166K USD) Innovate UK Grant to Develop AAV Scalable Production Bioprocess Cobra Biologics Recognised with CMO Leadership Award for Productivity PRODUCTIVITY AWARD: Business will treat the project as if it was their own Cobra and The University of Manchester Receive £217K Innovate UK / BBSRC Funding Awarded as part of £20M competition bringing innovative biotechnology projects to market BLOG: Disposable Solutions 2015 Tony Hitchcock's Pharma IQ Blog 2014 Highlights What a year 2014 has been! We've put together a brief round up of the highlights from Cobra... BLOG: If Single Use is Now the Norm Tony Hitchcock's Pharma IQ Blog BLOG: Where Next for Single Use Systems? Tony Hitchcock's Pharma IQ Blog Cobra Biologics and QuiaPEG Announce Strategic Collaboration Offering a Novel PEGylation Technology Platform Strategic alliance focused on the processing of biological drugs using a novel PEGylation platform. KUSBP Tenant Grows from One Office to Multinational Company Keele University Science & Business Park: Business Success Story Cobra Biologics Appoints CSO Cobra announces the appointment of Dr. Daniel C. Smith as Chief Scientific Officer Pagination Go to Previous page Go to page 6 Go to page 7 Go to page 8 Go to page 9
Alligator Bioscience AB Phase 1 Trial Benefits from Cobra Biologics' maxXpress Platform Alligator Bioscience AB Phase 1 Trial in Advanced Solid Tumours Benefits from Cobra Biologics' maxXpress Platform in Manufacturing Immuno-Oncology Antibody ADC-1013
Cobra Biologics and Tecrea Awarded £112K ($166K USD) Innovate UK Grant Cobra Biologics and Tecrea Awarded £112K ($166K USD) Innovate UK Grant to Develop AAV Scalable Production Bioprocess
Cobra Biologics Recognised with CMO Leadership Award for Productivity PRODUCTIVITY AWARD: Business will treat the project as if it was their own
Cobra and The University of Manchester Receive £217K Innovate UK / BBSRC Funding Awarded as part of £20M competition bringing innovative biotechnology projects to market
2014 Highlights What a year 2014 has been! We've put together a brief round up of the highlights from Cobra...
Cobra Biologics and QuiaPEG Announce Strategic Collaboration Offering a Novel PEGylation Technology Platform Strategic alliance focused on the processing of biological drugs using a novel PEGylation platform.
KUSBP Tenant Grows from One Office to Multinational Company Keele University Science & Business Park: Business Success Story
Cobra Biologics Appoints CSO Cobra announces the appointment of Dr. Daniel C. Smith as Chief Scientific Officer